COSMO PHARM N/ NL0011832936 /
8/30/2024 5:31:58 PM | Chg. +0.80 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
79.90CHF | +1.01% | 47,201 Turnover: 3.76 mill. |
71.00Bid Size: 150 | 80.00Ask Size: 2,000 | 1.3 bill.CHF | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 0.07 EUR | -93.23% |
EPS Diluted: | - EUR | -93.23% |
Revenues per Share: | 5.95 EUR | -5.27% |
Book Value per Share: | 26.25 EUR | -6.60% |
Cash Flow per Share: | 2.31 EUR | 6.89% |
Dividend per Share: | 2.00 EUR | 108.33% |
Total | in mill. | |
Revenues: | 96.72 EUR | -5.27% |
Net Income: | 1.15 EUR | -93.34% |
Operating Cash Flow: | 37.60 EUR | - |
Cash and Cash Equivalents: | 50.28 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 1,195.15 | 767.61 |
P/S Ratio: | 14.27 | 9.16 |
P/BV ratio: | 3.23 | 2.08 |
P/CF Ratio: | 36.69 | 23.57 |
PEG: | -12.82 | -8.23 |
Earnings Yield: | 0.08% | 0.13% |
Dividend Yield: | 2.36% | 3.67% |
Market Capitalization | ||
Market Capitalization: | 1.3 bill. CHF | 820.6 mill. CHF |
Free Float Market Cap.: | - CHF | - CHF |
Market Cap. / Employee: | 4.19 mill. CHF | 2.65 mill. CHF |
Shares Outstanding: | 16.26 mill. |
Profitability
Gross Profit Margin: | 59.33% |
EBIT Margin: | 12.64% |
Net Profit Margin: | 1.19% |
Return on Equity: | 0.27% |
Return on Assets: | 0.21% |
Financial Strength
Liquidity I / Cash Ratio: | 216.96% |
Liquidity II / Quick Ratio: | 339.76% |
Liquidity III / Current Ratio: | 441.16% |
Debt / Equity Ratio: | 29.81% |
Dynam. Debt / Equity Ratio: | 338.33% |
Efficiency
Employees: | 310 |
Personal Expenses / Employee: | - EUR |
Revenues / Employee: | 312,009.68 EUR |
Net Income / Employee: | 3,700.00 EUR |
Total Assets / Employee: | 1,787,032.26 EUR |
* Fiscal Year End: | 12/31/2023 |
Accounting Standard: | IFRS |
Currency: | EUR |